BioXcel Therapeutics Statistics

Total Valuation

BTAI has a market cap or net worth of $28.70 million. The enterprise value is $109.94 million.

Market Cap	28.70M
Enterprise Value	109.94M

Important Dates

The next estimated earnings date is Friday, May 8, 2026, before market open.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

BTAI has 27.07 million shares outstanding. The number of shares has increased by 381.58% in one year.

Current Share Class	27.07M
Shares Outstanding	27.07M
Shares Change (YoY)	+381.58%
Shares Change (QoQ)	+53.96%
Owned by Insiders (%)	0.32%
Owned by Institutions (%)	7.92%
Float	24.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	44.70
Forward PS	18.31
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	171.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.83

Current Ratio	0.83
Quick Ratio	0.53
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.96

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-75.47%
Return on Invested Capital (ROIC)	-265.48%
Return on Capital Employed (ROCE)	557.90%
Weighted Average Cost of Capital (WACC)	10.92%
Revenue Per Employee	$22,138
Profits Per Employee	-$2.41M
Employee Count	29
Asset Turnover	0.02
Inventory Turnover	0.23

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.32% in the last 52 weeks. The beta is 0.30, so BTAI's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	-43.32%
50-Day Moving Average	1.38
200-Day Moving Average	2.20
Relative Strength Index (RSI)	38.08
Average Volume (20 Days)	1,062,158

Short Selling Information

The latest short interest is 3.95 million, so 14.58% of the outstanding shares have been sold short.

Short Interest	3.95M
Short Previous Month	3.31M
Short % of Shares Out	14.58%
Short % of Float	16.00%
Short Ratio (days to cover)	3.99

Income Statement

In the last 12 months, BTAI had revenue of $642,000 and -$69.90 million in losses. Loss per share was -$5.73.

Revenue	642,000
Gross Profit	478,000
Operating Income	-50.27M
Pretax Income	-69.90M
Net Income	-69.90M
EBITDA	-49.97M
EBIT	-50.27M
Loss Per Share	-$5.73

Full Income Statement

Balance Sheet

The company has $28.42 million in cash and $109.66 million in debt, giving a net cash position of -$81.24 million or -$3.00 per share.

Cash & Cash Equivalents	28.42M
Total Debt	109.66M
Net Cash	-81.24M
Net Cash Per Share	-$3.00
Equity (Book Value)	-95.46M
Book Value Per Share	-4.28
Working Capital	-9.24M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-57.62M
Capital Expenditures	n/a
Depreciation & Amortization	300,000
Net Borrowing	n/a
Free Cash Flow	-57.62M
FCF Per Share	-$2.13

Full Cash Flow Statement

Margins

Gross Margin	74.45%
Operating Margin	-7,829.75%
Pretax Margin	-10,887.38%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BTAI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-381.58%
Shareholder Yield	-381.58%
Earnings Yield	-243.55%
FCF Yield	-200.76%

Analyst Forecast

The average price target for BTAI is $23.00, which is 2,069.81% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$23.00
Price Target Difference	2,069.81%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	146.68%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 10, 2025. It was a reverse split with a ratio of 1:16.

Last Split Date	Feb 10, 2025
Split Type	Reverse
Split Ratio	1:16

Scores

BTAI has an Altman Z-Score of -26.26 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-26.26
Piotroski F-Score	3